RCMI Coordinating Center (RCMI CC) Header Logo

Connection

William Pelham to Adrenergic Uptake Inhibitors

Back to Details
This is a "connection" page, showing publications William Pelham has written about Adrenergic Uptake Inhibitors.
William Pelham
Connection Strength
0.389
Adrenergic Uptake Inhibitors
  1. Waxmonsky JG, Waschbusch DA, Akinnusi O, Pelham WE. A comparison of atomoxetine administered as once versus twice daily dosing on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Feb; 21(1):21-32.
    View in: PubMed
    Score: 0.389
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support